eSignal IPO Calendar

Week of Expected Pricing	Pending
Company Name	LIRUM THERAPEUTICS, INC.
Proposed Ticker	LRTX
CUSIP	N/A
Business Description	We are an innovative, clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development, and commercialization of novel drug candidates with compelling mechanisms of action, regulatory pathways, and commercial opportunities.
Lead Underwriter	ThinkEquity LLC
Co-Managers	N/A
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A